Best Science Videos Podcasts (2024)

1
Pancreatic Cancer | Third Annual National General Medical Oncology Summit 48:34

4h ago48:34

48:34

Featuring perspectives from Dr Andrew H Ko and Dr Eileen M O’Reilly, including the following topics. Selection and Sequencing of Therapy for Patients with Metastatic Pancreatic Adenocarcinoma (PAD) — Dr Ko (0:00) Biomarker-Based Strategies for Metastatic PAD; Novel Investigational Approaches — Dr O’Reilly (31:46) CME information and select publicat…

1
Colorectal Cancer | Third Annual National General Medical Oncology Summit 49:20

4d ago49:20

49:20

Featuring perspectives from Dr Kristen K Ciombor and Dr John Strickler, including the following topics. Select Biomarker-Directed Approaches for Colorectal Cancer (CRC) — Dr Ciombor (0:00) HER2-Targeted Approaches for Metastatic CRC (mCRC); Other Available and Emerging Therapeutic Strategies — Dr Strickler (25:17) CME information and select publica…

1
Hepatobiliary Cancers | Third Annual National General Medical Oncology Summit 50:01

1d ago50:01

50:01

Featuring perspectives from Dr Ghassan Abou-Alfa and Dr Richard S Finn, including the following topics. Introduction (0:00) Hepatocellular Carcinoma (HCC) — Dr Abou-Alfa (8:30) Biliary Tract Cancers (BTCs) — Dr Finn (33:16) CME information and select publicationsBy Dr. Neil Love

1
Gastroesophageal Cancers | Third Annual National General Medical Oncology Summit 52:20

4d ago52:20

52:20

Featuring perspectives from Dr Yelena Y Janjigian and Dr Samuel J Klempner, including the following topics. Current and Potential Role of Immune Checkpoint Inhibitors in the Treatment of Gastroesophageal Cancers — Dr Klempner (0:00) Other Available and Emerging Therapeutic Approaches — Dr Janjigian (31:42) CME information and select publications…

1
Multiple Myeloma | Third Annual National General Medical Oncology Summit 50:10

2d ago50:10

50:10

Featuring perspectives from Dr Natalie S Callander and Dr Paul G Richardson, including the following topics. Introduction (0:00) Chimeric Antigen Receptor T-Cell Therapy, Bispecific Antibodies and Antibody-Drug Conjugates in Multiple Myeloma (MM) — Dr Callander (8:25) Integration of Other Novel Therapies into the Management of Newly Diagnosed and R…

1
Nontargeted Treatments for Lung Cancer | Third Annual National General Medical Oncology Summit 52:25

37m ago52:25

52:25

Featuring perspectives from Dr Edward B Garon and Dr Corey J Langer, including the following topics. Role of Immune Checkpoint Inhibitors in Nonmetastatic Non-Small Cell Lung Cancer (NSCLC) — Dr Langer (0:00) Immune Checkpoint Inhibitors and Other Emerging Therapeutic Approaches for Metastatic NSCLC without a Targetable Tumor Mutation — Dr Garon (3…

1
Targeted Therapy for Non-Small Cell Lung Cancer | Third Annual National General Medical Oncology Summit 49:27

4d ago49:27

49:27

Featuring perspectives from Dr Ibiayi Dagogo-Jack and Dr Henela Yu, including the following topics. Management of Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation — Dr Yu (0:00) Care of Individuals with Other Targetable Genomic Abnormalities — Dr Dagogo-Jack (31:01) CME information and select publications…

1
Prostate Cancer | Third Annual National General Medical Oncology Summit 51:51

41m ago51:51

51:51

Featuring perspectives from Dr Emmanuel S Antonarakis and Dr Rana R McKay, including the following topics. Role of Hormonal Therapy in Prostate Cancer (PC) Management — Dr McKay (0:00) Evidence-Based Use of Other Therapeutic Approaches — Dr Antonarakis (35:15) CME information and select publicationsBy Dr. Neil Love

1
Urothelial Bladder Cancer | Third Annual National General Medical Oncology Summit 47:00

2h ago47:00

47:00

Featuring perspectives from Dr Matthew D Galsky and Dr Jonathan E Rosenberg, including the following topics. Introduction (0:00) Nonmetastatic Urothelial Bladder Cancer (UBC) — Dr Galsky (5:45) Metastatic UBC — Dr Rosenberg (31:51) CME information and select publicationsBy Dr. Neil Love

1
Renal Cell Carcinoma | Third Annual National General Medical Oncology Summit 51:43

1h ago51:43

51:43

Featuring perspectives from Dr Eric Jonasch and DR Brian Rini, including the following topics. Introduction (0:00) Current Management of Metastatic Clear Cell Renal Cell Carcinoma (RCC) — Dr Rini (5:11) Treatment Approaches for Nonmetastatic RCC; Optimal Care of Patients with Non-Clear Cell RCC — Dr Jonasch (38:52) CME information and select public…

1
Metastatic HER2-Positive and Triple-Negative Breast Cancer | Third Annual National General Medical Oncology Summit 48:01

2h ago48:01

48:01

Featuring perspectives from Dr Erika Hamilton, Dr Virginia Kaklamani and Dr Hope S Rugo, including the following topics. HER2-Positive Metastatic Breast Cancer — Dr Hamilton (0:00) Metastatic Triple-Negative Breast Cancer — Dr Rugo (29:06) SABCS® 2023 Review — Dr Kaklamani (45:20) CME information and select publications…

1
Localized Breast Cancer | Third Annual National General Medical Oncology Summit 50:50

2h ago50:50

50:50

Featuring perspectives from Dr Virginia Kaklamani, Dr Kevin Kalinsky and Dr Joyce O’Shaughnessy, including the following topics. Introduction (0:00) Localized HER2-Positive and Triple-Negative Breast Cancer — Dr O’Shaughnessy (1:52) SABCS® 2023 Review — Dr Kaklamani (31:48) Localized ER-Positive Breast Cancer — Dr Kalinsky (38:10) CME information a…

1
Gynecologic Cancers | Third Annual National General Medical Oncology Summit 50:18

1h ago50:18

50:18

Featuring perspectives from Dr Bradley J Monk and Dr David M O’Malley, including the following topics. Introduction (0:00) Ovarian Cancer; Role of HER2-Directed Therapy in Gynecologic Cancers — Dr O’Malley (4:36) Endometrial Cancer and Cervical Cancer — Dr Monk (27:59) CME information and select publications…

1
Hodgkin and Non-Hodgkin Lymphoma | Third Annual National General Medical Oncology Summit 1:39:19

5d ago1:39:19

1:39:19

Featuring perspectives from Dr Ann S LaCasce, Dr Matthew Lunning, Dr Kami Maddocks and Dr Andrew D Zelenetz, including the following topics. Introduction (0:00) Follicular Lymphoma (FL) — Dr Zelenetz (2:29) Mantle Cell Lymphoma (MCL) — Dr Lunning (32:04) Hodgkin Lymphoma (HL) — Dr LaCasce (1:00:36) Diffuse Large B-Cell Lymphoma (DLBCL) — Dr Maddock…

1
ER-Positive Metastatic Breast Cancer | Third Annual National General Medical Oncology Summit 1:58:22

5d ago1:58:22

1:58:22

Featuring perspectives from Dr Erika Hamilton, Dr Kevin Kalinsky, Dr Joyce O’Shaughnessy and Dr Hope S Rugo, including the following topics. Introduction (0:00) Optimal Integration of CDK4/6 Inhibitors into the Management of ER-Positive Metastatic Breast Cancer (mBC) — Dr O’Shaughnessy (5:46) Role of Oral Selective Estrogen Receptor Degraders (SERD…

1
Ovarian Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Ovarian Cancer 1:31:00

1d ago1:31:00

1:31:00

Featuring perspectives from Dr Joyce F Liu, Dr Mansoor Raza Mirza and Dr David M O’Malley, moderated by Dr Kathleen N Moore, including the following topics: Introduction (0:00) Current Up-Front Treatment for Advanced Ovarian Cancer (OC) — Dr Liu (2:06) Potential Role of Immunotherapeutic Strategies for Advanced OC — Dr O’Malley (25:12) Incorporatio…

1
Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition (Companion Faculty ... 32:57

7d ago32:57

32:57

Featuring a slide presentation and related discussion from Dr Kanwal Raghav, including the following topics: Prevalence of HER2 alterations among patients with advanced gastrointestinal tumors beyond gastroesophageal cancer (0:00) Dual HER2 inhibition in the treatment of HER2-amplified colorectal cancer (CRC) (4:56) Efficacy and tolerability of the…

1
Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition 37:10

2d ago37:10

37:10

Featuring an interview with Dr Kanwal Raghav, including the following topics: Activity and tolerability of trastuzumab deruxtecan (T-DXd) in patients with HER2-expressing colorectal cancer (CRC) (0:00) Case: A woman in her mid 50s with multiregimen-refractory metastatic CRC receives T-DXd on a clinical trial (11:19) Case: A woman in her early 60s w…

1
Chronic Lymphocytic Leukemia | Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences 1:34:58

6d ago1:34:58

1:34:58

Featuring perspectives from Dr Bita Fakhri, including the following topics: Overview of select presentations from ASH 2023; recent FDA approval of lisocabtagene maraleucel (0:00) 6-year follow-up from the Phase III CLL14 trial of first-line venetoclax/obinutuzumab versus chlorambucil/obinutuzumab for chronic lymphocytic leukemia (CLL) (7:36) Update…

1
Unraveling Multi-Scale Fault Zone Behaviors with Small Earthquake Focal Mechanisms 1:00:00

8d ago1:00:00

1:00:00

Yifang Cheng, Tongji University, Shanghai Earthquake focal mechanisms offer insights into the architecture, kinematics, and stress at depth within fault zones, providing observations that complement surface geodetic measurements and seismicity statistics. We have improved the traditional focal mechanism calculation method, HASH, through the incorpo…

1
Colorectal Cancer | Arvind Dasari, MD, MS 53:56

10d ago53:56

53:56

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer | Faculty Presentation 2: Other Considerations in the Management of CRC — Arvind Dasari, MD, MS CME information and select publicationsBy Dr. Neil Love

1
Colorectal Cancer | Thierry André, MD 37:06

16d ago37:06

37:06

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer | Faculty Presentation 1: Targeted Treatment Approaches for Colorectal Cancer (CRC) — Thierry André, MD CME information and select publicationsBy Dr. Neil Love

1
Colorectal Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer 58:43

10d ago58:43

58:43

Featuring perspectives from Prof Thierry André and Dr Arvind Dasari, including the following topics: Introduction: Year in Review on the Ground (0:00) Treatment of HER2-Positive Colorectal Cancer (CRC) (7:50) Immune Checkpoint Inhibitors for Microsatellite Instability-High CRC (24:12) Other Key Issues (45:30) Questions and Cases from the Community …

1
Urothelial Bladder Cancer | Thomas Powles, MBBS, MRCP, MD 46:27

19d ago46:27

46:27

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer | Faculty Presentation 2: Metastatic Disease — Thomas Powles, MBBS, MRCP, MD CME information and select publicationsBy Dr. Neil Love

1
Urothelial Bladder Cancer | Shilpa Gupta, MD 45:24

19d ago45:24

45:24

Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer | Faculty Presentation 1: Nonmetastatic Urothelial Bladder Cancer (UBC) — Shilpa Gupta, MD CME information and select publicationsBy Dr. Neil Love

1
Urothelial Bladder Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer 1:00:57

19d ago1:00:57

1:00:57

Featuring perspectives from Dr Shilpa Gupta and Prof Thomas Powles, including the following topics: Introduction: The Cancer-Immunity Cycle (0:00) Nonmetastatic Urothelial Bladder Cancer — Dr Gupta (7:30) Metastatic Urothelial Bladder Cancer — Prof Powles (33:06) CME information and select publications…

1
B7-H3-Targeted Antibody-Drug Conjugates | Oncology Today with Dr Neil Love: The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates 1:14:03

20d ago1:14:03

1:14:03

Featuring perspectives from Dr Manish Patel, including the following topics: Insights into a comprehensive clinical research practice (0:00) Transformation of the conduct and design of clinical trials (3:41) Disparities and conundrums in clinical trial recruitment (10:11) Rationale of clinical trial dosing and regulatory initiatives (15:37) Innovat…

1
Offshore Fault Damage and Slip Behavior: Insights from Microseismicity and Seismic Imaging 1:00:00

15d ago1:00:00

1:00:00

Travis Alongi, U.S. Geological Survey Many of the world’s most damaging faults are offshore, presenting unique challenges and opportunities for studying earthquakes and faults. This talk explores how earthquake-generated (passive) and human-made (active) marine seismic methods improve our knowledge of on-fault slip behavior and off-fault dama…

1
April 2024 Quiz

23d ago

—

04/01/2024 | April 2024 QuizBy Elliot Fishman, MD

1
Prostate Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer 1:01:38

27d ago1:01:38

1:01:38

Featuring perspectives from Dr Andrew J Armstrong and Dr Maha Hussain, including the following topics: Introduction: Carpool Karaoke — RTP Style (0:00) Hormonal Therapy (13:36) Other Treatment Approaches (36:50) CME information and select publicationsBy Dr. Neil Love

1
Prostate Cancer | Andrew J Armstrong, MD, ScM 50:42

27d ago50:42

50:42

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer | Faculty Presentation 2: Other Available and Emerging Therapeutic Approaches in Prostate Cancer — Andrew J Armstrong, MD, ScM CME information and select publicationsBy Dr. Neil Love

1
Prostate Cancer | Maha Hussain, MD, FACP, FASCO 55:25

27d ago55:25

55:25

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer | Faculty Presentation 1: Optimizing the Role of Hormonal Therapy and Novel Therapeutic Strategies for Patients with Prostate Cancer — Maha Hussain, MD, FACP, FASCO CME information and select publications…

1
Lymphoma | Andrew M Evens, DO, MBA, MSc 1:00:58

28d ago1:00:58

1:00:58

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma | Faculty Presentation 2: Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma — Andrew M Evens, DO, MBA, MSc CME information and select publicationsBy Dr. Neil Love

1
Lymphoma | Sonali M Smith, MD 45:11

28d ago45:11

45:11

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma | Faculty Presentation 1: Follicular and Mantle Cell Lymphoma — Sonali M Smith, MD CME information and select publicationsBy Dr. Neil Love

1
Lymphoma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma 1:00:14

28d ago1:00:14

1:00:14

Featuring perspectives from Dr Andrew M Evens and Dr Sonali M Smith, including the following topics: Introduction: CD3-Based Bispecific Antibodies and the General Medical Oncologist: Lymphomas, Multiple Myeloma … and Solid Tumors? (0:00) Follicular and Mantle Cell Lymphoma (7:17) Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma (30:10) CME inform…

1
Variable short-term slip rate on the Imperial fault modulated by filling of the Salton Trough by Lake Cahuilla 1:00:00

22d ago1:00:00

1:00:00

Thomas Rockwell, San Diego State University The Salton Basin was free of significant water between about 100 BCE and 950 CE but has filled to the sill elevation of +13 m six times between ca 950 and 1730 CE. Based on a dense array of cone penetrometer (CPT) soundings across a small sag pond, the Imperial fault is interpreted to have experienced an …

1
ER-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer 1:19:56

29d ago1:19:56

1:19:56

Featuring perspectives from Dr Seth Wander, including the following topics: Case: A woman in her mid-50s with ER-positive, PR-negative, HER2 IHC 1+ metastatic breast cancer (mBC), Recurrence Score® (RS) = 35 (0:00) Mechanisms of resistance to antiestrogen therapy in HR-positive mBC (2:33) Optimal approaches to biomarker assessment (15:37) Case (con…

1
Hepatobiliary Cancers | Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review 1:01:41

1M ago1:01:41

1:01:41

Featuring perspectives from Dr Robin (Katie) Kelley and Dr Mark Yarchoan, including the following topics: Introduction: Interdisciplinary Management of Hepatocellular Carcinoma (HCC) in the Community (General Medical Oncology) Setting — Radiology, Hepatology, Pathology Support (0:00) Potential Role of Anti-PD-1/PD-L1 Antibodies in the Care of Patie…

1
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer 1:02:58

1M ago1:02:58

1:02:58

Featuring perspectives from Dr Melissa Johnson, including the following topics: Role of biomarker testing in optimal selection of first-line therapy for patients with non-small cell lung cancer (NSCLC) (0:00) Efficacy and safety with datopotamab deruxtecan for previously treated NSCLC (15:45) Antitumor activity with and current status of CEACAM5-ta…

1
Mechanics of caldera collapse earthquakes and their seismic representations 1:00:00

29d ago1:00:00

1:00:00

Taiyi Wang, Stanford University All instrumented basaltic caldera collapses generate Mw > 5 very long period earthquakes. However, previous studies of source dynamics have been limited to lumped models treating the caldera block as rigid, leaving open questions related to how ruptures initiate and propagate around the ring fault, and the seismic ex…

1
HER2-Positive and Triple-Negative Breast Cancer | Priyanka Sharma, MD 44:16

1M ago44:16

44:16

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer | Faculty Presentation 2: Triple-Negative Breast Cancer — Priyanka Sharma, MD CME information and select publicationsBy Dr. Neil Love

1
HER2-Positive and Triple-Negative Breast Cancer | Ian E Krop, MD, PhD 53:44

1M ago53:44

53:44

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer | Faculty Presentation 1: HER2-Positive Breast Cancer — Ian E Krop, MD, PhD CME information and select publicationsBy Dr. Neil Love

1
HER2-Positive and Triple-Negative Breast Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer 1:05:47

1M ago1:05:47

1:05:47

Featuring perspectives from Dr Ian E Krop and Dr Priyanka Sharma, including the following topics: Introduction: Educating Non-Breast Cancer Specialty Oncologists About HER2-Targeted Therapies – ASCO Genitourinary Cancers Symposium 2024 (0:00) HER2-Positive Breast Cancer — Dr Krop (12:30) Triple-Negative Breast Cancer — Dr Sharma (36:34) CME informa…

1
What does the 2024 M 7.5 Noto Hanto, Japan, quake tell us about short-term forecasting and long-term hazard? 1:00:00

1M ago1:00:00

1:00:00

Shinji Toda, Tohoku University The 1 Jan 2024 Noto Hanto earthquake launched a plethora of ills on the Noto Hanto population, taking 200 lives, and causing $25B in damage, only $5B of which was insured. These ills include a tsunami that arrived within a few minutes of the mainshock, as well as unexpectedly strong shaking throughout the Noto peninsu…

1
Metastatic Urothelial Bladder Cancer | Virtual Case Library: Metastatic Urothelial Bladder Cancer 2:07:55

1M ago2:07:55

2:07:55

Featuring perspectives from Dr Petros Grivas, Dr Vadim S Koshkin, Dr Kriti Mittal, Dr Mamta Parikh and Dr Scott T Tagawa, including the following topics: First-Line Treatment of Metastatic Urothelial Bladder Cancer (mUBC) — Enfortumab Vedotin/Pembrolizumab Case: A man in his late 80s with recurrent unresectable locally advanced UBC receives first-l…

1
ER-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive ... 40:38

1M ago40:38

40:38

Featuring a slide presentation and related discussion from Dr Komal Jhaveri, including the following topics: Role of ESR1 mutations in sensitivity and resistance to endocrine therapy in patients with ER-positive metastatic breast cancer (0:00) Efficacy and safety of oral SERDs in patients with ER-positive metastatic breast cancer (13:26) Similariti…

1
ER-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive ... 38:13

1M ago38:13

38:13

Featuring an interview with Dr Komal Jhaveri, including the following topics: Case: A woman in her mid 50s with ER-positive, HER2-low (IHC 1+) metastatic breast cancer with an ESR1 mutation (0:00) Case: A woman in her late 40s with ER-positive, HER2-low ESR1 wild-type metastatic breast cancer who received imlunestrant on a clinical trial (7:25) Cas…

1
Myelofibrosis | Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series 1:00:13

2M ago1:00:13

1:00:13

Featuring perspectives from Dr Stephen T Oh, including the following topics: Introduction: ASH 2023 Update (0:00) Case: A woman in her early 70s with symptomatic primary myelofibrosis (MF) receives ruxolitinib — Rao Mushtaq, MD (15:41) Case: A woman in her late 60s, a Jehovah’s Witness with multiple comorbidities, presents with splenomegaly and ane…

1
Gastroesophageal Cancers | Yelena Y Janjigian, MD 28:41

2M ago28:41

28:41

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers | Faculty Presentation 1: Immunotherapy in Gastroesophageal Cancers — Yelena Y Janjigian, MD CME information and select publicationsBy Dr. Neil Love

1
Gastroesophageal Cancers | Zev Wainberg, MD, MSc 36:20

2M ago36:20

36:20

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers | Faculty Presentation 2: Other Treatment Approaches for Gastroesophageal Cancers — Zev Wainberg, MD, MSc CME information and select publicationsBy Dr. Neil Love

Podcasts Worth a Listen

Science Videos Podcasts

Podcasts Worth a Listen

Quick Reference Guide